001     139529
005     20240511120146.0
024 7 _ |a 10.1038/tp.2017.202
|2 doi
024 7 _ |a pmid:28949335
|2 pmid
024 7 _ |a pmc:PMC5639246
|2 pmc
024 7 _ |a altmetric:26607141
|2 altmetric
037 _ _ |a DZNE-2020-05851
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Benito, E.
|0 P:(DE-2719)2810482
|b 0
|e First author
|u dzne
245 _ _ |a The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice.
260 _ _ |a London
|c 2017
|b Nature Publishing Group
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-09-26
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-09-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1715350888_4831
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Histone acetylation is essential for memory formation and its deregulation contributes to the pathogenesis of Alzheimer's disease. Thus, targeting histone acetylation is discussed as a novel approach to treat dementia. The histone acetylation landscape is shaped by chromatin writer and eraser proteins, while readers link chromatin state to cellular function. Chromatin readers emerged novel drug targets in cancer research but little is known about the manipulation of readers in the adult brain. Here we tested the effect of JQ1-a small-molecule inhibitor of the chromatin readers BRD2, BRD3, BRD4 and BRDT-on brain function and show that JQ1 is able to enhance cognitive performance and long-term potentiation in wild-type animals and in a mouse model for Alzheimer's disease. Systemic administration of JQ1 elicited a hippocampal gene expression program that is associated with ion channel activity, transcription and DNA repair. Our findings suggest that JQ1 could be used as a therapy against dementia and should be further tested in the context of learning and memory.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
542 _ _ |i 2017-09-01
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a (+)-JQ1 compound
|2 NLM Chemicals
650 _ 7 |a Amyloid beta-Protein Precursor
|2 NLM Chemicals
650 _ 7 |a Azepines
|2 NLM Chemicals
650 _ 7 |a BRDT protein, mouse
|2 NLM Chemicals
650 _ 7 |a Brd2 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Brd3 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Brd4 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Chromosomal Proteins, Non-Histone
|2 NLM Chemicals
650 _ 7 |a Nuclear Proteins
|2 NLM Chemicals
650 _ 7 |a Transcription Factors
|2 NLM Chemicals
650 _ 7 |a Triazoles
|2 NLM Chemicals
650 _ 2 |a Alzheimer Disease: genetics
|2 MeSH
650 _ 2 |a Amyloid beta-Protein Precursor: genetics
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Azepines: administration & dosage
|2 MeSH
650 _ 2 |a Behavior, Animal: drug effects
|2 MeSH
650 _ 2 |a Chromosomal Proteins, Non-Histone: antagonists & inhibitors
|2 MeSH
650 _ 2 |a Gene Expression: drug effects
|2 MeSH
650 _ 2 |a Hippocampus: drug effects
|2 MeSH
650 _ 2 |a Hippocampus: metabolism
|2 MeSH
650 _ 2 |a Hippocampus: physiology
|2 MeSH
650 _ 2 |a Long-Term Potentiation: drug effects
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Memory: drug effects
|2 MeSH
650 _ 2 |a Memory: physiology
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Mice, Transgenic
|2 MeSH
650 _ 2 |a Nuclear Proteins: antagonists & inhibitors
|2 MeSH
650 _ 2 |a Transcription Factors: antagonists & inhibitors
|2 MeSH
650 _ 2 |a Triazoles: administration & dosage
|2 MeSH
700 1 _ |a Ramachandran, B.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Schroeder, H.
|0 P:(DE-2719)2812036
|b 2
|u dzne
700 1 _ |a Schmidt, G.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Urbanke, H.
|0 P:(DE-2719)2811034
|b 4
|u dzne
700 1 _ |a Burkhardt, S.
|0 P:(DE-2719)2810773
|b 5
|u dzne
700 1 _ |a Capece, V.
|0 P:(DE-2719)2810626
|b 6
|u dzne
700 1 _ |a Dean, C.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fischer, A.
|0 P:(DE-2719)2000047
|b 8
|e Last author
|u dzne
773 1 8 |a 10.1038/tp.2017.202
|b : Springer Science and Business Media LLC, 2017-09-01
|n 9
|p e1239-e1239
|3 journal-article
|2 Crossref
|t Translational Psychiatry
|v 7
|y 2017
|x 2158-3188
773 _ _ |a 10.1038/tp.2017.202
|g Vol. 7, no. 9, p. e1239 - e1239
|0 PERI:(DE-600)2609311-X
|n 9
|q 7:9|p e1239
|t Translational Psychiatry
|v 7
|y 2017
|x 2158-3188
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/139529/files/DZNE-2020-05851.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/139529/files/DZNE-2020-05851.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639246
909 C O |o oai:pub.dzne.de:139529
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810482
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812036
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811034
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810773
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810626
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2000047
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b TRANSL PSYCHIAT : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-14T16:19:47Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-14T16:19:47Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-02-14T16:19:47Z
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b TRANSL PSYCHIAT : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 0
920 1 _ |0 I:(DE-2719)1440012
|k AG Bonn 2
|l Computational Systems Biology
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1410002
980 _ _ |a I:(DE-2719)1440012
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrn1604
|2 Crossref
|o 10.1038/nrn1604
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M402229200
|2 Crossref
|o 10.1074/jbc.M402229200
999 C 5 |9 -- missing cx lookup --
|a 10.1002/embj.201387637
|2 Crossref
|o 10.1002/embj.201387637
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrd4360
|2 Crossref
|o 10.1038/nrd4360
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nm.2828
|2 Crossref
|o 10.1038/nm.2828
999 C 5 |9 -- missing cx lookup --
|a 10.1146/annurev-pharmtox-011112-140216
|2 Crossref
|o 10.1146/annurev-pharmtox-011112-140216
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tips.2010.09.003
|2 Crossref
|o 10.1016/j.tips.2010.09.003
999 C 5 |9 -- missing cx lookup --
|a 10.1186/gb-2012-13-8-r68
|2 Crossref
|o 10.1186/gb-2012-13-8-r68
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M109.062422
|2 Crossref
|o 10.1074/jbc.M109.062422
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature07925
|2 Crossref
|o 10.1038/nature07925
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1186088
|2 Crossref
|o 10.1126/science.1186088
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2011-110080
|2 Crossref
|o 10.3233/JAD-2011-110080
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature09589
|2 Crossref
|o 10.1038/nature09589
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature09504
|2 Crossref
|o 10.1038/nature09504
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature10509
|2 Crossref
|o 10.1038/nature10509
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature10334
|2 Crossref
|o 10.1038/nature10334
999 C 5 |9 -- missing cx lookup --
|a 10.1158/2159-8290.CD-12-0418
|2 Crossref
|o 10.1158/2159-8290.CD-12-0418
999 C 5 |9 -- missing cx lookup --
|a 10.1136/annrheumdis-2014-205809
|2 Crossref
|o 10.1136/annrheumdis-2014-205809
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.yjmcc.2013.07.017
|2 Crossref
|o 10.1016/j.yjmcc.2013.07.017
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.0826-15.2015
|2 Crossref
|o 10.1523/JNEUROSCI.0826-15.2015
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.scr.2016.07.006
|2 Crossref
|o 10.1016/j.scr.2016.07.006
999 C 5 |9 -- missing cx lookup --
|a 10.1084/jem.20151271
|2 Crossref
|o 10.1084/jem.20151271
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nn.4095
|2 Crossref
|o 10.1038/nn.4095
999 C 5 |9 -- missing cx lookup --
|a 10.2174/1567205013666160427101832
|2 Crossref
|o 10.2174/1567205013666160427101832
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bioinformatics/bts635
|2 Crossref
|o 10.1093/bioinformatics/bts635
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bioinformatics/btu638
|2 Crossref
|o 10.1093/bioinformatics/btu638
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nprot.2012.016
|2 Crossref
|o 10.1038/nprot.2012.016
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s13059-014-0550-8
|2 Crossref
|o 10.1186/s13059-014-0550-8
999 C 5 |2 Crossref
|o
999 C 5 |9 -- missing cx lookup --
|a 10.1093/nar/gki475
|2 Crossref
|o 10.1093/nar/gki475
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bioinformatics/btp101
|2 Crossref
|o 10.1093/bioinformatics/btp101
999 C 5 |9 -- missing cx lookup --
|a 10.3389/fncel.2015.00023
|2 Crossref
|o 10.3389/fncel.2015.00023
999 C 5 |9 -- missing cx lookup --
|a 10.1101/cshperspect.a018663
|2 Crossref
|o 10.1101/cshperspect.a018663
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cell.2012.06.045
|2 Crossref
|o 10.1016/j.cell.2012.06.045
999 C 5 |y 2014
|2 Crossref
|o A Fischer 2014
999 C 5 |9 -- missing cx lookup --
|a 10.1172/JCI79942
|2 Crossref
|o 10.1172/JCI79942
999 C 5 |y 2016
|2 Crossref
|o J Shahbazi 2016
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1585183
|2 Crossref
|o 10.1126/science.1585183
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10339-011-0430-z
|2 Crossref
|o 10.1007/s10339-011-0430-z
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nmeth.2935
|2 Crossref
|o 10.1038/nmeth.2935
999 C 5 |9 -- missing cx lookup --
|a 10.1128/MCB.01353-13
|2 Crossref
|o 10.1128/MCB.01353-13
999 C 5 |9 -- missing cx lookup --
|a 10.1177/0022034514534261
|2 Crossref
|o 10.1177/0022034514534261
999 C 5 |9 -- missing cx lookup --
|a 10.4049/jimmunol.1202838
|2 Crossref
|o 10.4049/jimmunol.1202838
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1175371
|2 Crossref
|o 10.1126/science.1175371


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21